Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biohaven Taking Troriluzole Into Phase III OCD Study Despite Phase II/III Miss
Jun 25 2020
•
By
Mandy Jackson
Troriluzole was numerically but not statistically better than placebo • Source: Shutterstock
More from Clinical Trials
More from R&D